Table 7.
RLMa | HLMb | |||
---|---|---|---|---|
compound ID | T1/2 (min) | CLint (mL/min/mg) | T1/2 (min) | CLint (mL/min/mg) |
16c (4-Cl) | >120 | 0 | 102 | 6.78 |
16g (4-CF3) | >120 | 0 | >120 | 0 |
21a (4-F) | >120 | 0 | >120 | 0 |
26a (3-F, 4-Br) | >120 | 0 | >120 | 0 |
Compounds were incubated together with RLM with cofactors for phases I and II provided, as described in the Experimental Section.
Compounds were incubated together with HLM with cofactors for phases I and II provided, as described in the Experimental Section.